[EN] MK2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS MK2 ET UTILISATIONS ASSOCIÉES
申请人:CELGENE AVILOMICS RES INC
公开号:WO2014149164A1
公开(公告)日:2014-09-25
The present invention provides compounds, compositions thereof, and methods of using the same.
本发明提供了化合物、其组合物以及使用方法。
MK2 INHIBITORS AND USES THEREOF
申请人:CELGENE AVILOMICS RESEARCH, INC.
公开号:US20150376208A1
公开(公告)日:2015-12-31
The present invention provides compounds, compositions thereof, and methods of using the same.
本发明提供化合物,其组成物和使用方法。
PREPARATION METHOD FOR AROMATIC HETEROCYCLIC COMPOUND USED AS SELECTIVE JAK3 AND/OR JAK1 KINASE INHIBITOR AND APPLICATION OF AROMATIC HETEROCYCLIC COMPOUND
申请人:Shenzhen Chipscreen Biosciences, Ltd.
公开号:EP3196194A1
公开(公告)日:2017-07-26
An application of a compound having general formula (I) as JAK3 and/or JAK1 kinase and a preparation method for the compound.
一种具有通式(I)的化合物作为 JAK3 和/或 JAK1 激酶的应用及其制备方法。
Preparation method for aromatic heterocyclic compound used as selective JAK3 and/or JAK1 kinase inhibitor and application of aromatic heterocyclic compound
申请人:SHENZHEN CHIPSCREEN BIOSCIENCES, LTD.
公开号:US10011571B2
公开(公告)日:2018-07-03
An application of a compound having general formula (I) as JAK3 and/or JAK1 kinase and a preparation method for the compound.
一种具有通式(I)的化合物作为 JAK3 和/或 JAK1 激酶的应用及其制备方法。
MK2 inhibitors and uses thereof
申请人:Celgene CAR LLC
公开号:US10138256B2
公开(公告)日:2018-11-27
The present invention provides compounds, compositions thereof, and methods of using the same.